Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Davide Arillotta
Sign up to set email alerts
57
Publications
706
Citation Statements Received
3,304
Citation Statements Given
How they've been cited
907
25
680
1
How they cite others
3,453
66
3,231
7
Affiliations
University of Hertfordshire
,
University of Florence
Publications
Order By: Most citations
GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach
Arillotta
1
,
Floresta
2
,
Guirguis
3
et al.
2023
Brain Sciences
Abstract
Show
118
6
101
0
Get article
Add to collection
Cite
COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis
Arillotta
1
,
Guirguis
2
,
Corkery
3
et al.
2021
Brain Sciences
Abstract
Show
39
4
71
0
Get article
Add to collection
Cite
Novel Opioids: Systematic Web Crawling Within the e-Psychonauts’ Scenario
Arillotta
1
,
Schifano
2
,
Napoletano
3
et al.
2020
Front. Neurosci.
Abstract
Show
38
3
52
0
Get article
Add to collection
Cite
Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach
Catalani
1
,
Arillotta
2
,
Corkery
3
et al.
2021
Front. Psychiatry
Abstract
Show
38
1
52
0
Get article
Add to collection
Cite
The clinical challenges of synthetic cathinones
Schifano
1
,
Napoletano
2
,
Arillotta
3
et al.
2020
Brit J Clinical Pharma
Abstract
Show
74
1
42
0
Get article
Add to collection
Cite
Benefits and Harms of ‘Smart Drugs’ (Nootropics) in Healthy Individuals
Schifano
1
,
Catalani
2
,
Sharif
3
et al.
2022
Drugs
Abstract
Show
75
0
47
0
2
Get article
Add to collection
Cite
Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach
Arillotta
1
,
Floresta
2
,
Papanti Pelletier
et al.
2024
Brain Sciences
Abstract
Show
69
2
41
0
Get article
Add to collection
Cite
The Psychonauts’ World of Cognitive Enhancers
Napoletano
1
,
Schifano
2
,
Corkery
3
et al.
2020
Front. Psychiatry
Abstract
Show
47
1
37
0
Get article
Add to collection
Cite
1
2
3
4
5